We deliver market intelligence combining stock research, financial news, and earnings summaries to support data-driven investment decisions.
Syndax Pharmaceuticals Inc. (SNDX), a clinical-stage biopharmaceutical company focused on oncology therapeutic development, is trading at a current price of $24.85 as of 2026-04-06, marking a 1.19% decline in its most recent trading session. This analysis examines key technical levels, recent market context, and potential near-term price scenarios for the stock, with no recent earnings data available for the company as of this writing. The analysis is focused exclusively on observed price action
Is Syndax Pharmaceuticals (SNDX) Stock Near Support | Price at $24.85, Down 1.19% - Rating Change
SNDX - Stock Analysis
3645 Comments
831 Likes
1
Remberto
Registered User
2 hours ago
{协议答案}
👍 253
Reply
2
Tanayah
Insight Reader
5 hours ago
{协议答案}
👍 78
Reply
3
Kimoree
New Visitor
1 day ago
{协议答案}
👍 209
Reply
4
Kameko
New Visitor
1 day ago
{协议答案}
👍 101
Reply
5
Hobby
Loyal User
2 days ago
{协议答案}
👍 67
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.